Jenifer A Linehan
Papers
1
Total Citations
6
H-Index
1
About
Dr. Jenifer A. Linehan is a distinguished urologic oncologist whose research focuses on improving prostate cancer prognostication through novel biomarker integration and machine learning approaches. Her most cited work, a 2017 study on two-stage classifiers combining PCA3 and PSA proteolytic activity testing, demonstrated how combining molecular markers can significantly enhance prediction of biochemical recurrence after radical prostatectomy. This contribution addresses a critical clinical need—identifying patients at highest risk for early recurrence, which is linked to aggressive disease and cancer-specific mortality. Although her citation count reflects a specialized niche, her work represents an important step toward personalized risk stratification in prostate cancer management. Dr. Linehan’s research bridges the gap between emerging biomarkers and practical clinical decision-making, offering tools to better select patients for adjuvant therapies and intensive surveillance. Her contributions underscore the value of multivariate modeling in oncology, where single biomarkers often fall short. For students and researchers, her work exemplifies how integrating diverse data streams—from molecular assays to clinical variables—can refine prognostic accuracy and ultimately improve patient outcomes in urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1